Group 1 - The Hong Kong Innovative Drug ETF (159567) experienced a slight decline of 0.12% on December 10, with a trading volume of 755 million yuan [1] - The fund's shares increased by 53 million to a total of 10.414 billion shares, with a notable increase of 739 million shares over the past 20 trading days [1] - The latest net asset value of the fund is calculated to be 8.45 billion yuan [1] Group 2 - The performance benchmark for the Hong Kong Innovative Drug ETF is the National Index of Hong Kong Innovative Drugs, adjusted for valuation exchange rates [1] - The fund is managed by Yinhua Fund Management Co., Ltd., with Ma Jun as the fund manager [1] - Since its establishment on January 3, 2024, the fund has achieved a return of 62.28%, while the return over the past month has been -2.05% [1]
12月10日港股创新药ETF（159567）份额增加5300.00万份
Xin Lang Cai Jing·2025-12-11 01:13